Home > Financial Ratios > MANKIND PHARMA

MANKIND PHARMA
EV/CE

    Back to All Ratios
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year EV/CE History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EV/CE(x) 3.964.769.57-0.030.06

What is the latest EV/CE ratio of MANKIND PHARMA ?

The latest EV/CE ratio of MANKIND PHARMA is 3.96 based on Mar2026 Consolidated results.
Year EV/CE
Mar20263.96
Mar20254.76
Mar20249.57
Mar2023-0.03
Mar20220.06

How is EV/CE of MANKIND PHARMA Trending?

Years EV/CE % Change
Mar2026 3.96
-16.81
Mar2025 4.76
-50.26
Mar2024 9.57
Positive
Mar2023 -0.03
Negative
Mar2022 0.06 -

Other Financial Ratios of MANKIND PHARMA


Compare EV/CE ratio of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹94,040.1 Cr -1.9% -5.8% -12.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹441,958.0 Cr -3% -5.2% 17.9% Stock Analytics
DIVIS LABORATORIES ₹247,576.0 Cr 0.2% 9.7% 56.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,233.0 Cr 1.3% 2% 36.5% Stock Analytics
CIPLA ₹110,273.0 Cr -2.2% -6.6% -10.5% Stock Analytics
DR REDDYS LABORATORIES ₹96,906.4 Cr 1.4% -3.7% -8.8% Stock Analytics


MANKIND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-1.9%

-5.8%

-12.9%

SENSEX

-2.3%

-4.1%

-7.4%


You may also like the below Video Courses